Ketorolac in Palatoplasty

• Status: Recruiting
• Trial end date: 2023-06-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Treatments: Ketorolac

Criteria

Inclusion Criteria:

-Patient with Cleft palate (Complete and incomplete), with or without cleft lip, unilateral or bilateral

Exclusion Criteria:

• Syndromic Cleft Palate patients

• Previous palatoplasty

• Major unrepaired cardiac malformation

• History of GI complications (GI Bleed, Gastric Ulceration)

• History of Renal disorder

• History of coagulopathy (As contraindication to NSAID use)

• Feeding tube dependency

• Patients whose parents refuse to consent to randomization